Literature DB >> 11673685

Apoptosis and the response to anticancer therapy.

B M Mow1, A L Blajeski, J Chandra, S H Kaufmann.   

Abstract

Apoptosis is a distinctive form of cell death that reflects cleavage of a subset of intracellular polypeptides by proteases known as caspases. Two major intracellular caspase cascades, one activated predominantly by death receptor ligands and the other triggered by various cellular stresses, including DNA damage and microtubule disruption, have been delineated. Activation of these protease cascades is tightly regulated by a number of polypeptides, including Bcl-2 family members, inhibitor of apoptosis proteins, and several protein kinases. The demonstration that many antineoplastic agents induce apoptosis in susceptible cells raises the possibility that factors affecting caspase activation and activity might be important determinants of anticancer drug sensitivity. Here, we review recent studies describing the regulation of apoptotic pathways and identify potential implications of these findings for resistance to antineoplastic agents.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673685     DOI: 10.1097/00001622-200111000-00007

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  18 in total

1.  Poly(ADP-ribose) polymerase 1 modulates the lethality of CHK1 inhibitors in mammary tumors.

Authors:  Yong Tang; Hossein A Hamed; Andrew Poklepovic; Yun Dai; Steven Grant; Paul Dent
Journal:  Mol Pharmacol       Date:  2012-05-17       Impact factor: 4.436

2.  SMT-A07, a 3-(Indol-2-yl) indazole derivative, induces apoptosis of leukemia cells in vitro.

Authors:  Shijing Qian; Ji Cao; Yan Yan; Maotang Sun; Hong Zhu; Yongzhou Hu; Qiaojun He; Bo Yang
Journal:  Mol Cell Biochem       Date:  2010-08-06       Impact factor: 3.396

3.  Simultaneous exposure of transformed cells to SRC family inhibitors and CHK1 inhibitors causes cell death.

Authors:  Clint Mitchell; Hossein A Hamed; Nichola Cruickshanks; Yong Tang; M Danielle Bareford; Nissan Hubbard; Gary Tye; Adly Yacoub; Yun Dai; Steven Grant; Paul Dent
Journal:  Cancer Biol Ther       Date:  2011-08-01       Impact factor: 4.742

4.  Poly(ADP-ribose) polymerase 1 modulates the lethality of CHK1 inhibitors in carcinoma cells.

Authors:  Clint Mitchell; Margaret Park; Patrick Eulitt; Chen Yang; Adly Yacoub; Paul Dent
Journal:  Mol Pharmacol       Date:  2010-08-09       Impact factor: 4.436

5.  Sub-millimolar concentration of the novel phenol-based compound, 2-hydroxy benzoate zinc, induces apoptosis in human HT-1080 fibrosarcoma cells.

Authors:  J G Mahdi; C J Pepper; M A Alkarrawi; A J Mahdi; I D Bowen
Journal:  Cell Prolif       Date:  2009-11-17       Impact factor: 6.831

6.  Caspase 3-mediated inactivation of rac GTPases promotes drug-induced apoptosis in human lymphoma cells.

Authors:  Baolin Zhang; Yaqin Zhang; Emily Shacter
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

7.  Characterization of membrane potential-dependent uptake of the novel PET tracer 18F-fluorobenzyl triphenylphosphonium cation.

Authors:  Igal Madar; Hayden Ravert; Barry Nelkin; Masroor Abro; Martin Pomper; Robert Dannals; James J Frost
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-05       Impact factor: 9.236

8.  PARP and CHK inhibitors interact to cause DNA damage and cell death in mammary carcinoma cells.

Authors:  Laurence Booth; Nichola Cruickshanks; Thomas Ridder; Yun Dai; Steven Grant; Paul Dent
Journal:  Cancer Biol Ther       Date:  2013-05       Impact factor: 4.742

9.  Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs.

Authors:  Yukinori Takenaka; Tomoharu Fukumori; Tadashi Yoshii; Natsuo Oka; Hidenori Inohara; Hyeong-Reh Choi Kim; Robert S Bresalier; Avraham Raz
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

10.  UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.

Authors:  Guoyi Wu; Nan Lin; Linan Xu; Bo Liu; Mark A Feitelson
Journal:  BMC Cancer       Date:  2013-03-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.